# Chlorambucil

## Leukeran 2mg

| 藥物代碼           | OLEUK                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Management of chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL) and non-Hodgkin lymphomas (NHL).                                                                                                                                                                                                                                      |
| 副作用             | Bone marrow suppression; GI disturbances. Occasionally: severe interstitial pulmonary fibrosis; hepatotoxicity & jaundice. Fever, skin hypersensitivity, peripheral neuropathy, interstitial pneumonia & sterile cystitis. Seizures.                                                                                                          |
| 禁忌               | Hypersensitivity to chlorambucil or any component of the formulation; hypersensitivity to other alkylating agents (may have cross-hypersensitivity); prior (demonstrated) resistance to chlorambucil. Canadian labeling: Additional contraindications (not in US labeling): Use within 4 weeks of a full course of radiation or chemotherapy. |
| 藥物保存方式       | 2-8°C                                                                                                                                                                                                                                                                                                                                         |
| 用法用量           | Chronic lymphocytic leukemia (CLL): Oral: 0.1 mg/kg/day for 3 to 6 weeks or 0.4 mg/kg pulsed doses administered intermittently, biweekly, or monthly Hodgkin lymphoma: Oral: 0.2 mg/kg/day for 3 to 6 weeks. Non-Hodgkin lymphomas (NHL): Oral: 0.1 mg/kg/day for 3 to 6 weeks.                                                               |
| 肝功能異常         | 需 調 整 劑 量  有顯著肝功能障礙的病人,應考慮減少劑量                                                                                                                                                                                                                                                                                         |
| 腎功能異常         | 需 調 整 劑 量                                                                                                                                                                                                                                                                                                                                |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                      |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                           |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity(Mother) 無(很少)資料 - 避免使用(母體)                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                           |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                           |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                           |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                           |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                           |

